Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters.

ME, Harper; E, Glynne-Jones; L, Goddard; DW, Wilson; SS, Matenhelia; IG, Conn; WB, Peeling; K, Griffiths

doi:10.1002/pros.2990200309

Public

Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters.

Shared by NobleBlocks on Jan 1, 1992 • 12:00 AM UTC

Authors:

Harper ME

Glynne-Jones E

Goddard L

Abstract

Proliferating cell nuclear antigen (PCNA) expression was determined immunohistochemically, using a monoclonal antibody PC10, in 102 prostatic carcinoma samples and in prostate tissue from 21 patients with benign prostatic hyperplasis (BPH). The percentage of cells with stained nuclei ranged from 1% ...

Discussions